⌘K

Login Start Free

Home/Filings/4/0000905148-25-000168

4//SEC Filing

Miller Mary 4

Accession 0000905148-25-000168

CIK 0001781174other

View on SEC.gov Company Profile

Filed

Jan 21, 7:00 PM ET

Accepted

Jan 22, 4:15 PM ET

Size

4.4 KB

Accession

0000905148-25-000168

Insider Transaction Report

Form 4

Period: 2025-01-17

Acrivon Therapeutics, Inc.ACRV

Chief Legal Officer

Transactions

Tax Payment
Common Stock
2025-01-17$5.78/sh−659$3,809→ 37,282 total

Footnotes (1)

[F1]Shares withheld by the Issuer to satisfy the mandatory tax withholding requirement upon vesting of restricted stock units.

Documents

1 file

4
form4.xmlPrimary

Issuer

Acrivon Therapeutics, Inc.

CIK 0001781174

Entity typeother

Related Parties

1

filerCIK 0001841088

Filing Metadata

Form type: 4
Filed: Jan 21, 7:00 PM ET
Accepted: Jan 22, 4:15 PM ET
Size: 4.4 KB

View on SEC.gov